Transaction DateRecipientSharesTypePriceValue
5th February 2021R Neil Williams500Open or private sale$400.60$200,300.00
5th February 2021R Neil Williams2,388Exercise of derivative$12.30$29,372.40
5th February 2021R Neil Williams300Open or private sale$405.95$121,785.00
5th February 2021R Neil Williams300Open or private sale$401.62$120,486.00
5th February 2021R Neil Williams100Open or private sale$398.16$39,816.00
5th February 2021R Neil Williams400Open or private sale$404.36$161,744.00
5th February 2021R Neil Williams88Open or private sale$406.90$35,807.20
5th February 2021R Neil Williams400Open or private sale$399.63$159,852.00
5th February 2021R Neil Williams300Open or private sale$396.50$118,950.00
4th February 2021R Neil Williams688Open or private sale$396.84$273,025.92
Amyris logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 5/10.

Amyris, Inc. offers its products to health and wellness, clean beauty, and flavor and fragrance markets. The company was founded by Jack D. Newman, Kinkead Keith Reiling, and Neil Renninger on July 17, 2003.

Ticker: AMRS
Sector: Basic Materials
Industry: Specialty Chemicals
SEC Central Index Key (CIK): 1365916
Employees: 503
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Cash at Carrying Value: $100 M (0%)
Inventory, Net: $33 M (0%)
Other Assets, Current: $3 M (29%)
Assets, Current: $191 M (159%)
Property, Plant and Equipment, Net: $27 M (0%)
Other Assets, Noncurrent: $6 M (0%)
Assets: $268 M (66%)
Long-term Debt, Current Maturities: $43 M (-4%)
Accounts Payable, Current: $23 M (-55%)
Accrued Liabilities, Current: $49 M (0%)
Liabilities, Current: $129 M (-19%)
Long-term Debt, Excluding Current Maturities: $24 M (-51%)
Other Liabilities, Noncurrent: $15 M (0%)
Liabilities: $327 M (-20%)
Common Stock, Value, Issued: $20 Th (66%)
Common Stock, Shares, Issued: $205 M (73%)
Retained Earnings (Accumulated Deficit): $2 B (-2%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $49 M (11%)
Stockholders' Equity (Parent): $67 M (-73%)
Liabilities and Equity: $268 M (66%)
Cost of Revenue: $23 M (-33%)
Research and Development: $17 M (-50%)
Operating Income/Loss: $41 M (-43%)
Other Income, net: $67 M (-45%)
Income before taxes: $108 M (-44%)
Provision for income taxes: $99 Th (-47%)